Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
002038.SZ
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-0.00
vs 0.06
Q1.23
+228%
0.2
vs 0.06
Q2.23
+16%
0.11
vs 0.1
Q3.23
-99%
0
vs 0.07
Q4.23
N/A
0.1
vs NA
Q1.24
-65%
0.07
vs 0.2
Q2.24
N/A
-0.04
vs 0.11
Q3.24
N/A
-0.05
vs 0
Q4.24
N/A
-0.05
vs 0.1
Q1.25
-41%
0.04
vs 0.07
Sales Growth
YoY
Current
Estimates
Q1.23
-19%
223.2M vs 274.6M
Q1.23
+8%
296.6M vs 274.6M
Q2.23
+3%
286.9M vs 279.7M
Q3.23
-29%
193.1M vs 272.8M
Q4.23
NA
238.6M vs NA
Q1.24
-18%
243.5M vs 296.6M
Q2.24
-50%
144.4M vs 286.9M
Q3.24
-23%
148.5M vs 193.1M
Q4.24
-50%
119.9M vs 238.6M
Q1.25
-31%
168.9M vs 243.5M
Return on Equity
QoQ
Q2.23
+2%
0.02
vs 0.04
Q3.23
+0%
0
vs 0.02
Q4.23
+2%
0.02
vs 0
Q1.24
+1%
0.01
vs 0.02
Q2.24
-1%
-0.01
vs 0.01
Q3.24
-1%
-0.01
vs -0.01
Q4.24
-1%
-0.01
vs -0.01
Q1.25
+1%
0.01
vs -0.01
Institutionnal Ownership
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide; docetaxel; paclitaxel; filgrastim Recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; ciclosporin; mycophenolate mofetil dispersible; ornidazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; ademetionine 1,4-butanedisulfonate; glutathione; enoxaparin sodium; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; risedronate sodium; loratadine dispersible; somatostatin; octreotide acetate; calcitonin (salmon); paracetamol and tramadol hydrochloride; and etodolac. It also offers active pharmaceutical ingredients. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is based in Beijing, the People's Republic of China.
SHZ
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.02Â ( -0.27%)
Relative Strenght
Volume Buzz
-7%
Earning Acce
No
Dist 52w H.
15%Relative Strength
002038.SZ
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 002038.SZ compares to sector?